Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ RecruitingNot ApplicableIIT Clinical Study on the Effect of Neoantigens on the Therapeutic Efficacy and Intestinal Microbiota in Patients With Newly Diagnosed Glioma
The primary objective of this study is to assess the safety and tolerability, feasibility of the NeoPep Vaccine in newly diagnosed glioblastoma (GB) patients.
100 Clinical Results associated with Hangzhou NeoVax Biotechnology Co. LTD
0 Patents (Medical) associated with Hangzhou NeoVax Biotechnology Co. LTD
100 Deals associated with Hangzhou NeoVax Biotechnology Co. LTD
100 Translational Medicine associated with Hangzhou NeoVax Biotechnology Co. LTD